SILENCING GENES TO DISRUPT DISEASE
RNA interference (RNAi) is a naturally occurring process already at work inside your body which regulates how genes make new proteins. Proteins play a critical role in almost everything your body does, but sometimes, they can cause or contribute to disease. Our medicines leverage the RNAi process to selectively target and prevent specific unwanted proteins from being made, “silencing” gene expression to treat disease at its source..
We believe this revolutionary approach has the potential to address virtually any gene in the genome. This means that the diseases we treat today could be just the beginning of what's possible.
Learn more about RNAi
Learn more about our research, programs, company, culture, patient stories and more.
OUR FOCUS
Our robust pipeline of investigational RNAi therapeutics is focused on diseases with high unmet medical need in several therapeutic areas such as transthyretin amyloidosis (ATTR), rare diseases, cardiovascular diseases, metabolic diseases, neurologic diseases and others. We will always follow the science and are continually looking for new disease targets that may benefit from our science
JOIN OUR TEAM
We are dedicated, passionate people who want to "change the world" and who deeply believe in the power and potential of our technology and what we're building as a company. If you're looking for a mission, colleagues who inspire you, and a company that recognises and values both the collective and individual contributions, this could be your moment to join us.
CONTACT US
Alnylam UK Ltd.
Braywick Gate, Braywick Road, Maidenhead, Berkshire SL6 1DA
For medical information, clinical trial questions or to report an adverse event or product complaint:
Toll: +353 818 882213
Toll-free: 1800 924 260 (also hidden caller ID)
July 2025 Corp-IRL-00006
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to SiteYou will be directed to another Alnylam website that may contain information about specific treatment(s), news and more.
Proceed to Site
You will be redirected to an external site that may include social media, event registration, or other third-party content related to Alnylam.
Please note that these external sites have their own terms of service and privacy policies, which may differ from those of Alnylam.
Proceed to Site